BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 7679042)

  • 1. American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen.
    Mettlin C; Murphy GP; Ray P; Shanberg A; Toi A; Chesley A; Babaian R; Badalament R; Kane RA; Lee F
    Cancer; 1993 Feb; 71(3 Suppl):891-8. PubMed ID: 7679042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men.
    Mettlin C; Lee F; Drago J; Murphy GP
    Cancer; 1991 Jun; 67(12):2949-58. PubMed ID: 1710531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project.
    Mettlin C; Murphy GP; Babaian RJ; Chesley A; Kane RA; Littrup PJ; Mostofi FK; Ray PS; Shanberg AM; Toi A
    Cancer; 1996 Jan; 77(1):150-9. PubMed ID: 8630923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography. Findings of the American Cancer Society National Prostate Cancer Detection Project.
    Babaian RJ; Mettlin C; Kane R; Murphy GP; Lee F; Drago JR; Chesley A
    Cancer; 1992 Mar; 69(5):1195-200. PubMed ID: 1371233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project.
    Kane RA; Littrup PJ; Babaian R; Drago JR; Lee F; Chesley A; Murphy GP; Mettlin C
    Cancer; 1992 Mar; 69(5):1201-7. PubMed ID: 1371234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
    Mettlin C; Murphy GP; Lee F; Littrup PJ; Chesley A; Babaian R; Badalament R; Kane RA; Mostofi FK
    Cancer; 1993 Sep; 72(5):1701-8. PubMed ID: 7688658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
    Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
    Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients.
    Porter CR; Kim J
    Urology; 2004 Jan; 63(1):90-4. PubMed ID: 14751356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Prevalence and pathologic characteristics.
    Guthman DA; Wilson TM; Blute ML; Bergstralh EJ; Zincke H; Oesterling JE
    Urology; 1993 Aug; 42(2):150-4. PubMed ID: 7690170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of prostate cancer following repeated examinations by multiple modalities: results of the American Cancer Society National Prostate Cancer Detection Project.
    Mettlin C
    Clin Invest Med; 1993 Dec; 16(6):440-7. PubMed ID: 7516832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
    Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
    Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.
    Scattoni V; Roscigno M; Raber M; Montorsi F; Da Pozzo L; Guazzoni G; Freschi M; Rigatti P
    Eur Urol; 2003 Oct; 44(4):407-14. PubMed ID: 14499673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen, digital rectal examination, and transrectal ultrasound in predicting the probability of cancer.
    Drago JR; York JP
    J Surg Oncol; 1992 Mar; 49(3):172-5. PubMed ID: 1372376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
    Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
    Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
    Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
    NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].
    Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A
    Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.
    Candas B; Cusan L; Gomez JL; Diamond P; Suburu RE; Lévesque J; Brousseau G; Bélanger A; Labrie F
    Prostate; 2000 Sep; 45(1):19-35. PubMed ID: 10960839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic testing for prostate cancer detection: less is best.
    Babaian RJ; Dinney CP; Ramirez EI; Evans RB
    Urology; 1993 May; 41(5):421-5. PubMed ID: 7683834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.
    Labrie F; Dupont A; Suburu R; Cusan L; Gomez JL; Koutsilieris M; Diamond P; Emond J; Lemay M; Candas B
    Clin Invest Med; 1993 Dec; 16(6):425-39. PubMed ID: 7516831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.